Biopharma Comebacks With Vincerx's Ahmed Hamdy, MD

Source: Bioprocess Online

Ahmed Hamdy, MD didn’t ask to be the subject of Nathan Vardi's new book For Blood and Money: Billionaires, Biotech, and the Quest for a Blockbuster Drug.

In fact, that particular chapter of Dr. Hamdy’s career is one he’d rather not relive. But, in display of the resilience required of biotech leadership, Hamdy made a raging comeback. On this week’s episode of the Business of Biotech, we dive into Hamdy’s resurrection; how he shepherded Acerta Pharma all the way to a multibillion dollar blockbuster exit with Astra Zeneca and his plans to recreate that success in his new post as CEO and Founder at cancer therapeutics-focused Vincerx Pharma.


access the Podcast!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online